1. Home
  2. ACU vs MDWD Comparison

ACU vs MDWD Comparison

Compare ACU & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acme United Corporation.

ACU

Acme United Corporation.

HOLD

Current Price

$47.56

Market Cap

160.6M

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$14.56

Market Cap

181.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACU
MDWD
Founded
1867
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
160.6M
181.1M
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
ACU
MDWD
Price
$47.56
$14.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$50.00
$36.00
AVG Volume (30 Days)
15.0K
80.3K
Earning Date
04-23-2026
05-20-2026
Dividend Yield
1.56%
N/A
EPS Growth
1.63
N/A
EPS
0.24
N/A
Revenue
$196,541,816.00
N/A
Revenue This Year
$5.67
$48.92
Revenue Next Year
$5.25
$35.04
P/E Ratio
$196.63
N/A
Revenue Growth
1.05
N/A
52 Week Low
$35.50
$13.54
52 Week High
$50.00
$21.11

Technical Indicators

Market Signals
Indicator
ACU
MDWD
Relative Strength Index (RSI) 59.63 48.94
Support Level $43.36 $13.65
Resistance Level $50.00 $15.18
Average True Range (ATR) 1.44 0.51
MACD -0.16 0.02
Stochastic Oscillator 75.33 42.03

Price Performance

Historical Comparison
ACU
MDWD

About ACU Acme United Corporation.

Acme United Corp is a supplier of first aid and medical products and cutting technology to the school, home, office, hardware, sporting goods, and industrial markets. Its principal products sold across all segments are first aid kits and medical products, scissors, shears, knives, rulers, pencil sharpeners, and sharpening tools. The Company sells its products to mass market and e-commerce retailers, industrial distributors, wholesale, contract, and retail stationery distributors, office supply superstores, sporting goods stores, and hardware chains. The Company's reportable business segments consist of the United States, Canada, and Europe, out of which the majority of the company's revenue is derived from the United States.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: